The revenue stands at ₹7,474.66 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.29 per cent from ₹7,167.52 crore. This corresponds to a year-on-year *(YoY) growth of 31.89 per cent.
Operating Profit stands at ₹2,354.24 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.28 per cent from ₹1,835.28 crore. This corresponds to a year-on-year *(YoY) growth of 78.19 per cent.
PBDT stands at ₹2,374.79 crore, reflecting a quarter-on-quarter *(QoQ) increase of 29.42 per cent from ₹1,835.00 crore. This corresponds to a year-on-year *(YoY) growth of 84.23 per cent.
Profit Before Tax stands at ₹1,928.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 26.67 per cent from ₹1,522.04 crore. This corresponds to a year-on-year *(YoY) growth of 115.22 per cent.
Net Profit stands at ₹1,468.67 crore, reflecting a quarter-on-quarter *(QoQ) increase of 24.41 per cent from ₹1,180.51 crore. This represents a 87.72 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Lupin | 0.58% | 2.21% | 7.09% | 6.45% | 14.59% | 23.40% |
| Cipla | 1.00% | 2.13% | 5.55% | 22.75% | -2.84% | -3.16% |
| Dr Reddy's Labs | -1.41% | 2.15% | 5.24% | 12.21% | 6.75% | 6.26% |
| Zydus Lifesci. | -0.82% | 1.19% | 1.96% | 28.81% | 21.60% | 11.06% |
| Mankind Pharma | 2.81% | 2.99% | 9.90% | 27.43% | 16.10% | 11.41% |
| Aurobindo Pharma | 1.55% | 3.02% | 10.01% | 17.42% | 33.41% | 39.15% |
| Laurus Labs | 1.14% | 4.54% | 9.48% | 46.26% | 37.16% | 103.75% |
Chairman (Non-Executive) : M D Gupta
Managing Director : Nilesh Deshbandhu Gupta.
Director & Chief Executive Officer : Vinita Gupta
Company Sec. & Compli. Officer : R V Satam
Independent Director : Jean-Luc Belingard
Director & Group CFO : Ramesh Swaminathan
Independent Director : Mark D McDade
Independent Director : K B S Anand
Independent Director : Jeffrey Kindler
Independent Director : Alfonso Zulueta
Independent Director : Punita Lal